Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(10):803-804; doi:10.1093/jnci/djh151
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Barbanti-Brodano, G.
Right arrow Articles by Tognon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbanti-Brodano, G.
Right arrow Articles by Tognon, M.
Related Collections
Right arrowCorrespondence about this Article
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

CORRESPONDENCE

Re: Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans

Giuseppe Barbanti-Brodano, Alfredo Corallini, Roberto S. Accolla, Fernanda Martini, Mauro Tognon

Affiliations of authors: Department of Experimental and Diagnostic Medicine and Center of Biotechnology (GBB, AC), Center of Biotechnology and Department of Morphology and Embryology (FM, MT), University of Ferrara, Ferrara, Italy; Department of Clinical and Biological Sciences(RSA), University of Insubria, Varese, Italy.

Correspondence to: Mauro Tognon, PhD, Department of Morphology and Embryology, Chair of Applied Biology, School of Medicine, University of Ferrara, Via Fossato di Mortara 64/B, 44100 Ferrara, Italy (e-mail: tgm@unife.it)

The first 10% of the full text of this article appears below.

We read with interest the recent article by Carter et al. (1), in which human sera were screened for antibodies to simian virus 40 (SV40). Sera were screened for SV40 antibodies by an enzyme-linked immunosorbent assay using SV40 VP1 virus-like particles (VLPs) as antigens. Although the fraction of SV40-positive human sera (6.6%) in the Carter et al. study (1) is in agreement with the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Correspondence about this Article

RESPONSE: Re: Lack of Serologic Evidence for Prevalent Simian Virus 40 Infection in Humans
Denise A. Galloway and Joseph J. Carter
J Natl Cancer Inst 2004 96: 804-805. [Extract] [Full Text] [PDF]